ALLERGO-COMOD

This brand name is authorized in Austria, Hong Kong, Malta, Netherlands, Poland, Singapore

Active ingredients

The drug ALLERGO-COMOD contains one active pharmaceutical ingredient (API):

1 Disodium cromoglycate UNII Q2WXR1I0PK - CROMOLYN SODIUM

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils. Read about Cromoglicic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AC01	Cromoglicic acid	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids
Discover more medicines within R01AC01
S01GX01	Cromoglicic acid	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 63531
Country: MT	Medicines Authority	Identifier(s): MA063/00201
Country: NL	Z-Index G-Standaard	Identifier(s): 13973177
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 3131, 3506
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100112078
Country: SG	Health Sciences Authority	Identifier(s): 13423P